S1PR1 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, we evaluated the expression of S1P receptors (S1PR1-5) and the consequences of S1P receptor inhibition on K562 cell growth to further elucidate the downstream pathway mediating the influence of SIP on CML progression.